Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion
المؤلفون المشاركون
Menke, Marcel N.
Ebneter, Andreas
Zinkernagel, Martin S.
Wolf, Sebastian
المصدر
العدد
المجلد 2016، العدد 2016 (31 ديسمبر/كانون الأول 2016)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2016-12-01
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
Background.
Ranibizumab is approved for treatment of macular edema in eyes with retinal vein occlusion (RVO).
Some eyes show low-response to treatment with regard to visual acuity gain (VA) and OCT central retinal thickness (CRT) reduction.
The goal of this study was to quantify the percentage of low-responders.
Methods.
Treatment of naïve eyes with macular edema secondary to RVO was included and monthly VA and CRT were analyzed.
Four weeks after the loading phase, and at the end of the study, eyes were grouped into low- and good responders based on predefined criteria.
The responder and low-responder groups were then compared at various time points.
Results.
Forty-three eyes were included.
Regarding VA, 27.9% were low-responders after the loading phase and 30.2% at the end of the study.
For CRT, 34.9% were low-responders after the loading phase versus 27.9% at the end of the study.
75% of patients that were VA low-responders and 73.3% of CRT low-responders after loading phase remained low-responders at the end of the study.
Conclusion.
Approximately 30% of patients showed low response to ranibizumab after the loading phase and after 1 year of treatment.
Two-thirds of patients that were low-responders after the loading phase remained low-responders after 1 year.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Menke, Marcel N.& Ebneter, Andreas& Zinkernagel, Martin S.& Wolf, Sebastian. 2016. Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion. Journal of Ophthalmology،Vol. 2016, no. 2016, pp.1-6.
https://search.emarefa.net/detail/BIM-1110139
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Menke, Marcel N.…[et al.]. Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion. Journal of Ophthalmology No. 2016 (2016), pp.1-6.
https://search.emarefa.net/detail/BIM-1110139
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Menke, Marcel N.& Ebneter, Andreas& Zinkernagel, Martin S.& Wolf, Sebastian. Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion. Journal of Ophthalmology. 2016. Vol. 2016, no. 2016, pp.1-6.
https://search.emarefa.net/detail/BIM-1110139
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1110139
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر